Trial Profile
CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox in Hospitalized Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2014
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Acronyms CAPRIVI
- Sponsors Bayer
- 14 Nov 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.